These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Benzodiazepines in depressive disorders. Schatzberg AF; Cole JO Arch Gen Psychiatry; 1978 Nov; 35(11):1359-65. PubMed ID: 30428 [TBL] [Abstract][Full Text] [Related]
3. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Schosser A; Kasper S Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481 [TBL] [Abstract][Full Text] [Related]
4. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Borsini F; Podhorna J; Marazziti D Psychopharmacology (Berl); 2002 Sep; 163(2):121-41. PubMed ID: 12202959 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of generalized anxiety: new pharmacologic approaches]. Boulenger JP Encephale; 1995; 21(6):459-66. PubMed ID: 8674471 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetics and anxiety disorders: analysis of recent findings]. Amitai M; Kronenberg S; Cohen T; Frisch A; Weizman A; Apter A Harefuah; 2014; 153(3-4):210-4, 236. PubMed ID: 24791568 [TBL] [Abstract][Full Text] [Related]
7. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action. Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259 [TBL] [Abstract][Full Text] [Related]
8. The reappraisal of benzodiazepines in the treatment of anxiety and related disorders. Starcevic V Expert Rev Neurother; 2014 Nov; 14(11):1275-86. PubMed ID: 25242262 [TBL] [Abstract][Full Text] [Related]
9. 5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review. Olivier B; van Wijngaarden I; Soudijn W Eur Neuropsychopharmacol; 2000 Mar; 10(2):77-95. PubMed ID: 10706989 [TBL] [Abstract][Full Text] [Related]
10. [Use of benzodiazepines in the treatment of depression]. Escande M; Granier F; Girard M Encephale; 1983; 9(4 Suppl 2):273B-277B. PubMed ID: 6144524 [TBL] [Abstract][Full Text] [Related]
11. Preclinical characterization of ACH-000029, a novel anxiolytic compound acting on serotonergic and alpha-adrenergic receptors. Azevedo H; Ferreira M; Costa RW; Russo V; Russo E; Mascarello A; Guimarães CRW Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109707. PubMed ID: 31330215 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant and benzodiazepine for major depression. Furukawa TA; Streiner DL; Young LT Cochrane Database Syst Rev; 2002; (1):CD001026. PubMed ID: 11869584 [TBL] [Abstract][Full Text] [Related]
13. Antidepressant plus benzodiazepine for major depression. Furukawa TA; Streiner DL; Young LT Cochrane Database Syst Rev; 2001; (2):CD001026. PubMed ID: 11405972 [TBL] [Abstract][Full Text] [Related]
14. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders. Helton SG; Lohoff FW Pharmacogenomics; 2015; 16(5):541-53. PubMed ID: 25916524 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents. Jacobson LH; Cryan JF Neuropharmacology; 2008 Apr; 54(5):854-62. PubMed ID: 18328507 [TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic. Yokoyama F; Yamauchi M; Oyama M; Okuma K; Onozawa K; Nagayama T; Shinei R; Ishikawa M; Sato Y; Kakui N Psychopharmacology (Berl); 2009 Aug; 205(2):177-87. PubMed ID: 19357839 [TBL] [Abstract][Full Text] [Related]
17. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Bencan Z; Sledge D; Levin ED Pharmacol Biochem Behav; 2009 Nov; 94(1):75-80. PubMed ID: 19643124 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for the rational use of benzodiazepines. When and what to use. Ashton H Drugs; 1994 Jul; 48(1):25-40. PubMed ID: 7525193 [TBL] [Abstract][Full Text] [Related]